Sera Prognostics (SERA) Competitors $8.78 +0.65 (+8.00%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends SERA vs. PNTG, AVAH, AGL, CSTL, GRAL, INNV, FLGT, AUNA, DCGO, and CELCShould you be buying Sera Prognostics stock or one of its competitors? The main competitors of Sera Prognostics include The Pennant Group (PNTG), Aveanna Healthcare (AVAH), agilon health (AGL), Castle Biosciences (CSTL), Grail (GRAL), InnovAge (INNV), Fulgent Genetics (FLGT), Auna (AUNA), DocGo (DCGO), and Celcuity (CELC). These companies are all part of the "healthcare" industry. Sera Prognostics vs. The Pennant Group Aveanna Healthcare agilon health Castle Biosciences Grail InnovAge Fulgent Genetics Auna DocGo Celcuity Sera Prognostics (NASDAQ:SERA) and The Pennant Group (NASDAQ:PNTG) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, analyst recommendations, dividends, institutional ownership, community ranking, media sentiment, valuation, profitability and risk. Is SERA or PNTG more profitable? The Pennant Group has a net margin of 3.24% compared to Sera Prognostics' net margin of 0.00%. The Pennant Group's return on equity of 13.47% beat Sera Prognostics' return on equity.Company Net Margins Return on Equity Return on Assets Sera PrognosticsN/A -51.73% -36.94% The Pennant Group 3.24%13.47%3.81% Do analysts rate SERA or PNTG? The Pennant Group has a consensus price target of $37.20, suggesting a potential upside of 35.87%. Given The Pennant Group's higher probable upside, analysts plainly believe The Pennant Group is more favorable than Sera Prognostics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sera Prognostics 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00The Pennant Group 0 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.60 Does the media prefer SERA or PNTG? In the previous week, The Pennant Group had 5 more articles in the media than Sera Prognostics. MarketBeat recorded 6 mentions for The Pennant Group and 1 mentions for Sera Prognostics. The Pennant Group's average media sentiment score of 0.40 beat Sera Prognostics' score of 0.00 indicating that The Pennant Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Sera Prognostics 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral The Pennant Group 0 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has higher earnings and valuation, SERA or PNTG? The Pennant Group has higher revenue and earnings than Sera Prognostics. Sera Prognostics is trading at a lower price-to-earnings ratio than The Pennant Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSera Prognostics$94K3,154.45-$36.24M-$0.99-8.87The Pennant Group$652.30M1.44$13.38M$0.6840.26 Does the MarketBeat Community prefer SERA or PNTG? The Pennant Group received 30 more outperform votes than Sera Prognostics when rated by MarketBeat users. Likewise, 46.51% of users gave The Pennant Group an outperform vote while only 38.46% of users gave Sera Prognostics an outperform vote. CompanyUnderperformOutperformSera PrognosticsOutperform Votes1038.46% Underperform Votes1661.54% The Pennant GroupOutperform Votes4046.51% Underperform Votes4653.49% Which has more volatility & risk, SERA or PNTG? Sera Prognostics has a beta of 0.92, suggesting that its share price is 8% less volatile than the S&P 500. Comparatively, The Pennant Group has a beta of 1.95, suggesting that its share price is 95% more volatile than the S&P 500. Do insiders & institutionals believe in SERA or PNTG? 54.6% of Sera Prognostics shares are owned by institutional investors. Comparatively, 85.9% of The Pennant Group shares are owned by institutional investors. 15.8% of Sera Prognostics shares are owned by company insiders. Comparatively, 5.8% of The Pennant Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. SummaryThe Pennant Group beats Sera Prognostics on 15 of the 18 factors compared between the two stocks. Ad Paradigm Press Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again with Tesla… which is up more than 19,500% since 2010. For perspective, that turns $100 invested into almost $20,000!Click here now for the urgent details. Get Sera Prognostics News Delivered to You Automatically Sign up to receive the latest news and ratings for SERA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SERA vs. The Competition Export to ExcelMetricSera PrognosticsMedical laboratories IndustryMedical SectorNASDAQ ExchangeMarket Cap$296.52M$2.93B$5.14B$9.08BDividend YieldN/A15.63%5.09%4.23%P/E Ratio-8.8716.0290.0517.18Price / Sales3,154.45284.461,117.14116.99Price / CashN/A472.1143.0437.86Price / Book3.975.194.784.78Net Income-$36.24M-$32.86M$120.31M$225.60M7 Day Performance1.86%-3.01%-1.92%-1.23%1 Month Performance43.70%2.96%11.51%3.36%1 Year Performance32.03%12.37%30.61%16.60% Sera Prognostics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SERASera Prognostics0.2225 of 5 stars$8.78+8.0%N/A+28.2%$296.52M$94,000.00-8.87120News CoveragePositive NewsPNTGThe Pennant Group4.5661 of 5 stars$29.62+1.8%$38.25+29.1%+100.7%$1.02B$544.89M42.815,791Analyst ForecastNews CoveragePositive NewsAVAHAveanna Healthcare0.9169 of 5 stars$4.98-1.0%$4.27-14.3%+82.5%$962.26M$1.98B-14.7933,500Positive NewsAGLagilon health2.3055 of 5 stars$2.20-1.8%$4.28+94.7%-84.0%$906.44M$5.59B-2.381,117Gap DownCSTLCastle Biosciences2.7304 of 5 stars$28.65-0.8%$39.71+38.6%+34.4%$802.40M$311.88M144.35540Insider TradeGRALGrail0.4714 of 5 stars$22.77+2.8%$16.00-29.7%N/A$765.10M$117.67M0.001,360Gap DownINNVInnovAge1.2807 of 5 stars$4.54+2.3%$6.50+43.2%-25.4%$614.97M$786.51M-37.002,350Analyst ForecastNews CoverageFLGTFulgent Genetics3.8217 of 5 stars$19.66+0.4%$22.00+11.9%-35.9%$601.34M$277.76M-3.551,184News CoveragePositive NewsAUNAAuna3.2194 of 5 stars$6.73+3.4%$13.40+99.1%N/A$497.47M$4.34B0.0014,958News CoverageDCGODocGo2.5861 of 5 stars$4.46+4.0%$6.10+36.8%-15.2%$455.15M$694.97M15.324,164CELCCelcuity2.6094 of 5 stars$12.12-3.2%$29.17+140.6%-13.6%$450.02MN/A-4.8040News CoverageHigh Trading Volume Related Companies and Tools Related Companies PNTG Competitors AVAH Competitors AGL Competitors CSTL Competitors GRAL Competitors INNV Competitors FLGT Competitors AUNA Competitors DCGO Competitors CELC Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:SERA) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sera Prognostics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sera Prognostics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SERA Stock Alerts